News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,594 Results
Type
Article (44909)
Company Profile (263)
Press Release (698409)
Multimedia
Podcasts (101)
Webinars (20)
Section
Business (206287)
Career Advice (2105)
Deals (35783)
Drug Delivery (139)
Drug Development (82955)
Employer Resources (175)
FDA (16682)
Job Trends (15174)
News (350324)
Policy (33290)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2687)
Accelerated approval (51)
Adcomms (28)
Allergies (176)
Alliances (49920)
ALS (215)
Alzheimer's disease (1814)
Antibody-drug conjugate (ADC) (483)
Approvals (17076)
Artificial intelligence (681)
Autoimmune disease (312)
Automation (57)
Bankruptcy (364)
Best Places to Work (11771)
BIOSECURE Act (20)
Biosimilars (224)
Biotechnology (170)
Bladder cancer (202)
Brain cancer (76)
Breast cancer (774)
Cancer (6031)
Cardiovascular disease (492)
Career advice (1792)
Career pathing (43)
CAR-T (344)
CDC (64)
Celiac Disease (3)
Cell therapy (933)
Cervical cancer (50)
Clinical research (72064)
Collaboration (2100)
Company closure (5)
Compensation (1414)
Complete response letters (82)
COVID-19 (2798)
CRISPR (111)
C-suite (1160)
Cystic fibrosis (155)
Data (8199)
Decentralized trials (3)
Denatured (28)
Depression (167)
Dermatology (91)
Diabetes (609)
Diagnostics (7034)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (331)
Drug pricing (215)
Drug shortages (32)
Duchenne muscular dystrophy (289)
Earnings (92344)
Editorial (70)
Employer branding (22)
Employer resources (154)
Events (121993)
Executive appointments (1096)
FDA (20486)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1757)
Gene editing (242)
Generative AI (56)
Gene therapy (742)
GLP-1 (1092)
Government (4864)
Grass and pollen (6)
Guidances (411)
Healthcare (19468)
HIV (82)
Huntington's disease (56)
IgA nephropathy (101)
Immunology and inflammation (296)
Immuno-oncology (102)
Indications (197)
Infectious disease (3151)
Inflammatory bowel disease (219)
Inflation Reduction Act (14)
Influenza (139)
Intellectual property (299)
Interviews (328)
IPO (16750)
IRA (50)
Job creations (3698)
Job search strategy (1490)
JPM (58)
Kidney cancer (19)
Labor market (105)
Layoffs (571)
Leadership (40)
Legal (8079)
Liver cancer (102)
Longevity (33)
Lung cancer (796)
Lymphoma (441)
Machine learning (60)
Management (60)
Manufacturing (1073)
MASH (201)
Medical device (14043)
Medtech (14175)
Mergers & acquisitions (20297)
Metabolic disorders (1563)
mRNA (217)
Multiple sclerosis (192)
NASH (17)
Neurodegenerative disease (431)
Neuropsychiatric disorders (108)
Neuroscience (3374)
Neurotech (1)
NextGen: Class of 2026 (6662)
Non-profit (4709)
Now hiring (79)
Obesity (728)
Opinion (299)
Ovarian cancer (232)
Pain (261)
Pancreatic cancer (314)
Parkinson's disease (376)
Partnered (33)
Patents (607)
Patient recruitment (693)
Peanut (62)
People (60353)
Pharmaceutical (58)
Pharmacy benefit managers (35)
Phase 1 (22439)
Phase 2 (31700)
Phase 3 (23608)
Pipeline (9086)
Policy (339)
Postmarket research (2703)
Preclinical (9642)
Press Release (65)
Prostate cancer (316)
Psychedelics (54)
Radiopharmaceuticals (339)
Rare diseases (1104)
Real estate (6042)
Recruiting (70)
Regulatory (25840)
Reports (56)
Research institute (2467)
Resumes & cover letters (357)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (180)
Series A (294)
Series B (215)
Service/supplier (11)
Sickle cell disease (118)
Special edition (26)
Spinal muscular atrophy (168)
Sponsored (48)
Startups (3668)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (91)
The Weekly (71)
Vaccines (1135)
Venture capital (111)
Weight loss (471)
Women's health (128)
Worklife (21)
Date
Today (1)
Last 7 days (609)
Last 30 days (3097)
Last 365 days (30238)
2026 (13764)
2025 (30384)
2024 (35473)
2023 (40360)
2022 (51490)
2021 (56022)
2020 (54581)
2019 (47257)
2018 (35567)
2017 (32479)
2016 (32009)
2015 (38088)
2014 (31883)
2013 (27007)
2012 (29252)
2011 (29918)
2010 (28248)
Location
Africa (768)
Alabama (93)
Alaska (7)
Arizona (353)
Arkansas (14)
Asia (40337)
Australia (6677)
California (13558)
Canada (3833)
China (1401)
Colorado (577)
Connecticut (588)
Delaware (415)
Europe (87706)
Florida (2026)
Georgia (436)
Hawaii (3)
Idaho (63)
Illinois (1088)
India (93)
Indiana (612)
Iowa (24)
Japan (554)
Kansas (132)
Kentucky (51)
Louisiana (45)
Maine (76)
Maryland (1627)
Massachusetts (9721)
Michigan (372)
Minnesota (732)
Mississippi (6)
Missouri (146)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (86)
New Jersey (3561)
New Mexico (30)
New York (3547)
North Carolina (1727)
North Dakota (10)
Northern California (6828)
Ohio (404)
Oklahoma (24)
Oregon (42)
Pennsylvania (2716)
Puerto Rico (29)
Rhode Island (51)
South America (1159)
South Carolina (86)
South Dakota (2)
Southern California (5349)
Tennessee (216)
Texas (2161)
United States (47868)
Utah (404)
Vermont (1)
Virginia (326)
Washington D.C. (82)
Washington State (1085)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
743,594 Results for "american regent inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Endogenex Announces Publication of REGENT-1 Clinical Study Results in Diabetes, Obesity and Metabolism
March 17, 2026
·
4 min read
Press Releases
American Aires Inc. Announces Updates on Annual Filings, Litigation and Listing Matters, Cease Trade Order, and 2024 Financial Statements
May 8, 2026
·
5 min read
Press Releases
American Aires Inc. Files Legal Proceedings Against Former Executive
March 13, 2026
·
6 min read
Press Releases
SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting
April 6, 2026
·
12 min read
Press Releases
Modular Genetics, Inc. joins New American Industrial Alliance to Reindustrialize America
March 5, 2026
·
1 min read
Press Releases
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
April 21, 2026
·
4 min read
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
February 16, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Foundayo and Zepbound now covered for millions of Americans
May 28, 2026
·
22 min read
Policy
American Regent Introduces Potassium Phosphates, USP; FDA-Approved and “AP” Rated¹
American Regent announces the launch and availability of Potassium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Potassium Phosphates.1 Potassium Phosphates Injection, USP is indicated as a source of phosphorus:
October 19, 2023
·
9 min read
Pharm Country
American Regent Introduces Levocarnitine Injection, USP; FDA-Approved, AP Rated, and Therapeutically Equivalent to Carnitor®¹
American Regent announces the release and availability of Levocarnitine Injection, USP, FDA-approved, “AP” rated, and therapeutically equivalent to Carnitor®.
October 10, 2023
·
6 min read
1 of 74,360
Next
